Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA): A Pilot Randomized Controlled Trial and Translational Biology Study

NCT05868109 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT05868109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05868109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA): A Pilot Randomized Controlled Trial and Translational Biology Study
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2022
Completion date
January 31, 2026
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest